Explore national- and state-level data for hundreds of health, environmental and socioeconomic measures, including background information about each measure. Use features on this page to find measures; view subpopulations, trends and rankings; and download and share content.
Ohio Value:
Percentage of adults age 65 and older who reported ever receiving a pneumonia vaccine
Ohio Rank:
Explore Population Data:
Appears In:
Percentage of adults age 65 and older who reported ever receiving a pneumonia vaccine
US Value: 69.6%
Top State(s): Colorado: 77.2%
Bottom State(s): Hawaii: 62.0%
Definition: Percentage of adults age 65 and older who reported ever receiving a pneumonia vaccine
Data Source and Years(s): CDC, Behavioral Risk Factor Surveillance System, 2022
Suggested Citation: America's Health Rankings analysis of CDC, Behavioral Risk Factor Surveillance System, United Health Foundation, AmericasHealthRankings.org, accessed 2024.
The Centers for Disease Control and Prevention recommends all adults age 65 and older receive a vaccine that helps protect against pneumococcal disease. Pneumococcal disease refers to any infection caused by bacteria called Streptococcus pneumoniae. These bacteria can cause many kinds of infections, including pneumonia, ear infections, sinus infections and meningitis. While most pneumococcal infections are mild, some can be fatal, or lead to long-term complications like brain damage or hearing loss.
Hospitalization and death rates from pneumococcal infections are highest among older adults. Pneumococcal conjugate vaccines (PCV15 and PCV20) and pneumococcal polysaccharide vaccine (PPSV23) are the two types of vaccines recommended to protect against pneumococcal disease in the United States. The incidence of invasive pneumococcal disease decreased significantly with the introduction and uptake of pneumococcal vaccines in adults and children.
Every year, approximately 1.5 million individuals in the U.S. are diagnosed with pneumonia, and of these, 1 million are hospitalized. Despite the increased risk older adults face, pneumococcal vaccination rates among older adults in the U.S. remain below recommended levels, especially within racial and ethnic minority groups.
According to America’s Health Rankings, the prevalence of pneumococcal vaccination is higher among:
Strategies to increase pneumococcal vaccinations among older adults include:
Additionally, the American Academy of Family Physicians has established grants to support quality improvement initiatives to increase the rates of pneumococcal vaccinations among adults in Kansas, Illinois and New Jersey.
Healthy People 2030 has an objective to reduce the rate of hospital admissions for pneumonia among older adults.
Gierke, Ryan, Lesley McGee, Bernard Beall, and Tamara Pilishivili. “Chapter 11: Pneumococcal.” In Manual for the Surveillance of Vaccine-Preventable Diseases, edited by Sandra W. Roush, Linda M. Baldy, and Mary Ann Kirkconnell Hall. Centers for Disease Control and Prevention, Department of Health and Human Services, 2020. https://www.cdc.gov/vaccines/pubs/surv-manual/chpt11-pneumo.html.
Hayes, Brandon H., Dana L. Haberling, Jordan L. Kennedy, Jay K. Varma, Alicia M. Fry, and Neil M. Vora. “Burden of Pneumonia-Associated Hospitalizations.” Chest 153, no. 2 (February 2018): 427–37. https://doi.org/10.1016/j.chest.2017.09.041.
Ho, Hanley J., Yi-Roe Tan, Alex R. Cook, Gerald Koh, Tat Yean Tham, Eve Anwar, Grace Shu Hui Chiang, May O. Lwin, and Mark I. Chen. “Increasing Influenza and Pneumococcal Vaccination Uptake in Seniors Using Point-of-Care Informational Interventions in Primary Care in Singapore: A Pragmatic, Cluster-Randomized Crossover Trial.” American Journal of Public Health 109, no. 12 (October 17, 2019): 1776–83. https://doi.org/10.2105/AJPH.2019.305328.
Thomas, Roger E. “Pneumococcal Pneumonia and Invasive Pneumococcal Disease in Those 65 and Older: Rates of Detection, Risk Factors, Vaccine Effectiveness, Hospitalisation and Mortality.” Geriatrics 6, no. 1 (February 4, 2021): 13. https://doi.org/10.3390/geriatrics6010013.
Valdez, R. Burciaga, and Korazon S. Romero. “Improving Adult Vaccination Status in the United States.” Healthcare 9, no. 11 (October 21, 2021): 1411. https://doi.org/10.3390/healthcare9111411.
Williams, Walter W., Peng-Jun Lu, Alissa O’Halloran, David K. Kim, Lisa A. Grohskopf, Tamara Pilishvili, Tami H. Skoff, et al. “Surveillance of Vaccination Coverage among Adult Populations — United States, 2015.” MMWR. Surveillance Summaries 66, no. 11 (May 5, 2017): 1–28. https://doi.org/10.15585/mmwr.ss6611a1.
Wroe, Peter C., Jonathan A. Finkelstein, G. Thomas Ray, Jeffrey A. Linder, Kristen M. Johnson, Sheryl Rifas-Shiman, Matthew R. Moore, and Susan S. Huang. “Aging Population and Future Burden of Pneumococcal Pneumonia in the United States.” The Journal of Infectious Diseases 205, no. 10 (May 15, 2012): 1589–92. https://doi.org/10.1093/infdis/jis240.
America’s Health Rankings builds on the work of the United Health Foundation to draw attention to public health and better understand the health of various populations. Our platform provides relevant information that policymakers, public health officials, advocates and leaders can use to effect change in their communities.
We have developed detailed analyses on the health of key populations in the country, including women and children, seniors and those who have served in the U.S. Armed Forces, in addition to a deep dive into health disparities across the country.